Tiziana Life Sciences (LON:TILS) Stock Price Up 8.3% – Here’s What Happened

Tiziana Life Sciences PLC (LON:TILS)’s stock price was up 8.3% during trading on Friday . The stock traded as high as GBX 59 ($0.74) and last traded at GBX 58.50 ($0.74). Approximately 297,127 shares changed hands during mid-day trading, a decline of 43% from the average daily volume of 522,223 shares. The stock had previously closed at GBX 54 ($0.68).

Tiziana Life Sciences Price Performance

The company has a current ratio of 6.54, a quick ratio of 6.41 and a debt-to-equity ratio of 2.36. The firm’s 50-day moving average price is GBX 58.50 and its two-hundred day moving average price is GBX 58.50. The stock has a market cap of £113.85 million and a PE ratio of -3.59.

Tiziana Life Sciences Company Profile

Tiziana Life Sciences Plc, a clinical stage biotechnology company, focuses on the discovery and development of molecules and related diagnostics to treat diseases in oncology and immunology in the United Kingdom. Its product pipeline includes Foralumab (TZLS-401), a human anti-CD3 monclonal antibody for the treatment of autoimmune and inflammatory diseases, such as GvHD, ulcerative colitis, Crohn's disease, multiple sclerosis, type-1 diabetes, inflammatory bowel diseases, psoriasis, and rheumatoid arthritis; and Milciclib (TZLS-201), which is an orally bioavailable, small molecule inhibitor of cyclin-dependent kinases and Src family kinases for the treatment of hepatocellular carcinoma.